Seres Therapeutics, Inc.MCRBNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-120.30M
↓ 22% below average
Average (9y)
$-98.48M
Historical baseline
Range
High:$-54.13M
Low:$-181.42M
CAGR
+9.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-120.30M | +33.7% |
| 2023 | $-181.42M | -6.1% |
| 2022 | $-170.93M | -201.4% |
| 2021 | $-56.72M | +26.6% |
| 2020 | $-77.31M | -24.3% |
| 2019 | $-62.17M | +31.7% |
| 2018 | $-91.08M | -10.9% |
| 2017 | $-82.12M | +7.3% |
| 2016 | $-88.63M | -63.7% |
| 2015 | $-54.13M | - |